{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:01:39Z","timestamp":1776747699624,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12185-025-04027-8","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:12:06Z","timestamp":1751256726000},"page":"744-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of leukapheresis in managing complications of hyperleukocytosis in pediatric acute leukemia"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9544-4098","authenticated-orcid":false,"given":"Alper","family":"Uygun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-9626","authenticated-orcid":false,"given":"Canan","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-7435","authenticated-orcid":false,"given":"\u00dcnsal","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0407-5635","authenticated-orcid":false,"given":"O\u011fuz Salih","family":"Din\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6115-1254","authenticated-orcid":false,"given":"H\u00fclya","family":"Kangal \u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-9956","authenticated-orcid":false,"given":"\u0130brahim","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"4","key":"4027_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/children9040503","volume":"9","author":"SR Jones","year":"2022","unstructured":"Jones SR, Rahrig A, Saraf AJ. Leukapheresis in pediatric acute leukemia with hyperleukocytosis: a single-center experience. Children. 2022;9(4):503.","journal-title":"Children"},{"issue":"9","key":"4027_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1200\/JCO.1988.6.9.1425","volume":"6","author":"HS Maurer","year":"1988","unstructured":"Maurer HS, Steinherz P, Gaynon P, Finklestein J, Sather H, Reaman G, et al. The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia. J Clin Oncol. 1988;6(9):1425\u201332.","journal-title":"J Clin Oncol"},{"key":"4027_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-015-0387-8","volume":"17","author":"A Ruggiero","year":"2016","unstructured":"Ruggiero A, Rizzo D, Amato M, Riccardi R. Management of hyperleukocytosis. Curr Treat Options Oncol. 2016;17:1\u201310.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"4027_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000210392","volume":"121","author":"MA Ozdemir","year":"2009","unstructured":"Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematol. 2009;121(1):56\u201362.","journal-title":"Acta Haematol"},{"issue":"6","key":"4027_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s12185-023-03665-0","volume":"118","author":"A Zhang","year":"2023","unstructured":"Zhang A, Liu L, Zong S, Chang L, Chen X, Yang W, et al. Pediatric Acute Myeloid Leukemia and Hyperleukocytosis with WBC count greater than 50\u00d7 109\/L. Int J Hematol. 2023;118(6):737\u201344.","journal-title":"Int J Hematol"},{"issue":"1","key":"4027_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5045\/br.2014.49.1.29","volume":"49","author":"SG Kong","year":"2014","unstructured":"Kong SG, Seo JH, Jun SE, Lee BK, Lim YT. Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation. Blood research. 2014;49(1):29\u201335.","journal-title":"Blood research"},{"issue":"1\u20132","key":"4027_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428190009053534","volume":"39","author":"P Porcu","year":"2000","unstructured":"Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000;39(1\u20132):1\u201318.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4027_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3324\/haematol.2012.065490","volume":"97","author":"L Sung","year":"2012","unstructured":"Sung L, Aplenc R, Alonzo TA, Gerbing RB, Gamis AS. Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children\u2019s Oncology Group. Haematologica. 2012;97(11):1770.","journal-title":"Haematologica"},{"issue":"4","key":"4027_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/pbc.25855","volume":"63","author":"U Creutzig","year":"2016","unstructured":"Creutzig U, R\u00f6ssig C, Dworzak M, Stary J, von Stackelberg A, W\u00f6ssmann W, et al. Exchange transfusion and leukapheresis in pediatric patients with AML with high risk of early death by bleeding and leukostasis. Pediatr Blood Cancer. 2016;63(4):640\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"4027_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8355","author":"D Findakly","year":"2020","unstructured":"Findakly D, Luther RD III, Wang J, Findakly D. Tumor lysis syndrome in solid tumors: a comprehensive literature review, new insights, and novel strategies to improve outcomes. Cureus. 2020. https:\/\/doi.org\/10.7759\/cureus.8355.","journal-title":"Cureus"},{"issue":"5","key":"4027_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/biomedicines10051012","volume":"10","author":"G Lupu\u0219oru","year":"2022","unstructured":"Lupu\u0219oru G, Ailinc\u0103i I, Fr\u0103\u021bil\u0103 G, Ungureanu O, Andronesi A, Lupu\u0219oru M, et al. Tumor lysis syndrome: an endless challenge in onco-nephrology. Biomedicines. 2022;10(5):1012.","journal-title":"Biomedicines"},{"issue":"1","key":"4027_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MPH.0000000000002225","volume":"44","author":"SA Gelen","year":"2022","unstructured":"Gelen SA, Sarper N, Zengin E, Azizo\u011flu M. Management of hyperleukocytosis in childhood acute leukemia without leukapheresis and rasburicase prophylaxis. J Pediatr Hematol Oncol. 2022;44(1):12\u20138.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"4027_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/MPH.0000000000000490","volume":"38","author":"O Abla","year":"2016","unstructured":"Abla O, Angelini P, Di Giuseppe G, Kanani MF, Lau W, Hitzler J, et al. Early complications of hyperleukocytosis and leukapheresis in childhood acute leukemias. J Pediatr Hematol Oncol. 2016;38(2):111\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"06","key":"4027_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1055\/s-0029-1239533","volume":"221","author":"R Haase","year":"2009","unstructured":"Haase R, Merkel N, Diwan O, Elsner K, Kramm C. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klin Paediatr. 2009;221(06):374\u20138.","journal-title":"Klin Paediatr"},{"key":"4027_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00467-004-1524-y","volume":"19","author":"RJ Macfarlane","year":"2004","unstructured":"Macfarlane RJ, McCully BJ, Fernandez CV. Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis. Pediatr Nephrol. 2004;19:924\u20137.","journal-title":"Pediatr Nephrol"},{"key":"4027_CR16","doi-asserted-by":"publisher","first-page":"1155481","DOI":"10.3389\/fped.2023.1155481","volume":"11","author":"D Zhang","year":"2023","unstructured":"Zhang D, Lin H, Huang L. Repeated small-volume exchange transfusion for hyperleukocytosis in pediatric acute leukemia: a retrospective analysis. Front Pediatr. 2023;11:1155481.","journal-title":"Front Pediatr"},{"issue":"3","key":"4027_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/cncr.23581","volume":"113","author":"H Inaba","year":"2008","unstructured":"Inaba H, Fan Y, Pounds S, Geiger TL, Rubnitz JE, Ribeiro RC, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113(3):522\u20139.","journal-title":"Cancer"},{"issue":"8","key":"4027_CR18","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1097\/MPH.0000000000000207","volume":"36","author":"V Gr\u00e8ze","year":"2014","unstructured":"Gr\u00e8ze V, Chambon F, Merlin E, Rochette E, Isfan F, Dem\u00e9ocq F, et al. Leukapheresis in management of hyperleukocytosis in children\u2019s leukemias. J Pediatr Hematol Oncol. 2014;36(8):e513\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"4027_CR19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/pbc.26056","volume":"63","author":"R Nguyen","year":"2016","unstructured":"Nguyen R, Jeha S, Zhou Y, Cao X, Cheng C, Bhojwani D, et al. The role of leukapheresis in the current management of hyperleukocytosis in newly diagnosed childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2016;63(9):1546\u201351.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4027_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.leukres.2014.01.004","volume":"38","author":"S Oberoi","year":"2014","unstructured":"Oberoi S, Lehrnbecher T, Phillips B, Hitzler J, Ethier M-C, Beyene J, et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res. 2014;38(4):460\u20138.","journal-title":"Leuk Res"},{"issue":"4","key":"4027_CR21","first-page":"899","volume":"35","author":"B Naeem","year":"2019","unstructured":"Naeem B, Moorani KN, Anjum M, Imam U. Tumor lysis syndrome in pediatric acute lymphoblastic leukemia at tertiary care center. Pakistan J Med Sci. 2019;35(4):899.","journal-title":"Pakistan J Med Sci"},{"issue":"6","key":"4027_CR22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s12185-024-03752-w","volume":"119","author":"Y Toda","year":"2024","unstructured":"Toda Y, Ashizawa M, Murahashi R, Nakashima H, Ikeda T, Kawaguchi S-I, et al. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era. Int J Hematol. 2024;119(6):660\u20136.","journal-title":"Int J Hematol"},{"key":"4027_CR23","unstructured":"Castillo L, Janic D, Jazbec APDJ, Kaiserova E, Konja J, Kovacs G, et al. ALL IC-BFM 2009."},{"issue":"Supplement 1","key":"4027_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1182\/blood-2020-139189","volume":"136","author":"K Waack","year":"2020","unstructured":"Waack K, Schneider M, Walter C, Creutzig U, Klusmann J-H, Rasche M, et al. Improved outcome in pediatric AML \u2013 the AML-BFM 2012 study. Blood. 2020;136(Supplement 1):12\u20134.","journal-title":"Blood"},{"issue":"1","key":"4027_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3\u201311.","journal-title":"Br J Haematol"},{"issue":"4","key":"4027_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/MPH.0000000000001771","volume":"42","author":"KM Park","year":"2020","unstructured":"Park KM, Yang EJ, Lee JM, Hah JO, Park SK, Park ES, et al. Treatment outcome in pediatric acute lymphoblastic leukemia with hyperleukocytosis in the Yeungnam Region of Korea: a multicenter retrospective study. J Pediatr Hematol Oncol. 2020;42(4):275\u201380.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"16","key":"4027_CR27","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui C-H, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767\u201378.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4027_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/08880018.2013.818747","volume":"31","author":"D Yilmaz","year":"2014","unstructured":"Yilmaz D, Karapinar B, Karada\u015f N, Duyu M, Yazici P, Ay Y, et al. Leukapheresis in childhood acute leukemias: single-center experience. Pediatr Hematol Oncol. 2014;31(4):318\u201326.","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"4027_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, et al. Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence\u2010based approach from the Writing Committee of the American Society for Apheresis: the Ninth Special Issue. J Clin Apher. 2023;38(2):77\u2013278.","journal-title":"J Clin Apher"},{"issue":"3","key":"4027_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.transci.2012.03.012","volume":"46","author":"D Veljkovi\u0107","year":"2012","unstructured":"Veljkovi\u0107 D, Kuzmanovi\u0107 M, Mi\u0107i\u0107 D, \u0160erbi\u0107-Nonkovi\u0107 O. Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia. Transfus Apheres Sci. 2012;46(3):263\u20137.","journal-title":"Transfus Apheres Sci"},{"key":"4027_CR31","doi-asserted-by":"publisher","DOI":"10.5812\/ijp-148313","author":"\u00d6 Terzi","year":"2024","unstructured":"Terzi \u00d6, Aycicek A, Uysalol EP, Erturk S, Hancerli O, Solgun HA, et al. Leukapheresis in pediatric acute leukemia with hyperleukocytosis: a single center experience. Innov J Pediatr. 2024. https:\/\/doi.org\/10.5812\/ijp-148313.","journal-title":"Innov J Pediatr"},{"issue":"3","key":"4027_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.blre.2012.01.003","volume":"26","author":"C Ganzel","year":"2012","unstructured":"Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012;26(3):117\u201322.","journal-title":"Blood Rev"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04027-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T20:37:10Z","timestamp":1761770230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4027"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04027-8","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no personal or financial conflicts of interest in this study. This study was not funded by any commercial entity or organization.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}